Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03768505
Brief Title: Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)

First Submitted : December 4, 2018
First Submitted that Met QC Criteria : December 6, 2018
First Posted : December 7, 2018

Last Update Submitted that Met QC Criteria : April 7, 2021
Last Update Posted : April 8, 2021